As a promising marker, LCR has demonstrated higher ability in predicting cancer surgery and oncological outcomes in gastric cancer, rectal cancer, and cholangiocarcinoma compared to NLR, CRP, nutritional risk index (NRI), PLR, PI, PNI, GPS, and mGPS [12–17]. The gene discussed is CRP; the disease is cancer.